Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An update on non-Hodgkin's lymphomas

D M Lundquist1, F M Stewart

  • 1University of Massachusetts Medical Center, Worcester.

The Nurse Practitioner
|October 1, 1994
PubMed
Summary

Non-Hodgkin's lymphomas are diverse lymph node diseases. Diagnosis and staging guide treatment, with observation for asymptomatic indolent cases and immediate therapy for aggressive lymphomas.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two locus models of selection and mutation within and among full-sib lines.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

Floating treatment wetlands for domestic wastewater treatment.

Water science and technology : a journal of the International Association on Water Pollution Research·2011
Same author

Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission.

Leukemia·2010
Same author

Murine marrow cellularity and the concept of stem cell competition: geographic and quantitative determinants in stem cell biology.

Leukemia·2004
Same author

Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series.

BJOG : an international journal of obstetrics and gynaecology·2002
Same author

Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming with successive concomitant low-dose Ara-C for elderly patients with secondary/refractory acute myeloid leukemia or advanced myelodysplastic syndrome.

Leukemia·2002

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Non-Hodgkin's lymphomas (NHL) encompass a heterogeneous group of lymphoid malignancies.
  • Characterized by lymphadenopathy, NHL can be indolent or aggressive, with histopathology guiding prognosis.
  • Etiology remains unknown in most cases, with painless peripheral adenopathy as a common presentation.

Purpose of the Study:

  • To outline the diagnostic and therapeutic strategies for non-Hodgkin's lymphomas.
  • To emphasize the importance of histopathologic subtyping for disease classification.
  • To guide clinical staging and treatment decisions based on lymphoma grade and patient symptoms.

Main Methods:

  • Clinical staging without laparotomy is recommended for assessing disease extent.
  • Histopathologic subtyping is crucial for determining lymphoma characteristics.
  • Treatment decisions are based on lymphoma grade (indolent vs. aggressive) and patient symptomatology.

Main Results:

  • Indolent lymphomas may be observed if asymptomatic; symptomatic patients require treatment.
  • Aggressive lymphomas necessitate immediate treatment with curative intent.
  • High-dose therapy with bone marrow transplantation offers a curative option for relapsed cases.

Conclusions:

  • Accurate staging and histopathologic subtyping are essential for effective non-Hodgkin's lymphoma management.
  • Treatment strategies should be tailored to lymphoma aggressiveness and patient condition.
  • Advanced therapies like bone marrow transplantation can be curative in select relapsed patients.

Related Experiment Videos